A Glimpse Into The Expert Outlook On Apellis Pharmaceuticals Through 20 Analysts
A Glimpse Into The Expert Outlook On Apellis Pharmaceuticals Through 20 Analysts
通過20位分析師對apellis pharmaceuticals的專家展望的簡要介紹
A comprehensive examination...Providing a diverse range of perspectives from bullish to bearish, 20 analysts have published ratings on Apellis Pharmaceuticals (NASDAQ:APLS) in the last three months.
在過去三個月中，有20位分析師就Apellis Pharmaceuticals (納斯達克股票代碼：APLS) 發佈了從看好到看淡的多元化觀點。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級概況，突出了過去30天內情緒的變化，並將其與之前的月份進行了比較。
Analysts have set 12-month price targets for Apellis Pharmaceuticals, revealing an average target of $45.35, a high estimate of $92.00, and a low estimate of $24.00. A 23.06% drop is evident in the current average compared to the previous average price target of $58.94.
分析師爲Apellis Pharmaceuticals設定了12個月的價格目標，顯示平均目標爲45.35美元，最高估值爲92.00美元，最低估值爲24.00美元。與先前的平均目標價格58.94美元相比，當前平均價格下跌了23.06%。
Diving into Analyst Ratings: An In-Depth Exploration
深入探討分析師評級：分析師評級的深度探討
A comprehensive examination...
最近分...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間